NasdaqCM - Nasdaq Real Time Price USD

LENSAR, Inc. (LNSR)

Compare
7.64 +0.07 (+0.92%)
At close: December 11 at 4:00:01 PM EST
7.64 0.00 (0.00%)
After hours: December 11 at 6:59:11 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
48,868.00
42,164.00
35,358.00
34,459.00
26,382.00
Cost of Revenue
24,976.00
21,057.00
15,403.00
16,626.00
12,307.00
Gross Profit
23,892.00
21,107.00
19,955.00
17,833.00
14,075.00
Operating Expense
32,499.00
33,336.00
40,132.00
37,485.00
32,577.00
Operating Income
-8,607.00
-12,229.00
-20,177.00
-19,652.00
-18,502.00
Net Non Operating Interest Income Expense
--
--
--
--
-1,340.00
Other Income Expense
-8,021.00
-2,154.00
263.00
51.00
68.00
Pretax Income
-16,628.00
-14,383.00
-19,914.00
-19,601.00
-19,774.00
Net Income Common Stockholders
-16,628.00
-14,383.00
-19,914.00
-19,601.00
-19,774.00
Diluted NI Available to Com Stockholders
-16,628.00
-14,383.00
-19,914.00
-19,601.00
-19,774.00
Basic EPS
-1.46
-1.31
-1.96
-2.09
-4.28
Diluted EPS
-1.46
-1.31
-1.96
-2.09
-4.28
Basic Average Shares
11,421.00
10,971.00
10,159.00
9,374.00
4,621.00
Diluted Average Shares
11,421.00
10,971.00
10,159.00
9,374.00
4,621.00
Total Operating Income as Reported
-12,336.00
-12,229.00
-20,177.00
-19,652.00
-18,502.00
Total Expenses
57,475.00
54,393.00
55,535.00
54,111.00
44,884.00
Net Income from Continuing & Discontinued Operation
-16,628.00
-14,383.00
-19,914.00
-19,601.00
-19,774.00
Normalized Income
-7,863.00
-11,531.00
-19,914.00
-19,601.00
-19,774.00
Interest Expense
--
--
--
--
1,340.00
Net Interest Income
--
--
--
--
-1,340.00
EBIT
-8,607.00
-12,229.00
-20,177.00
-19,652.00
-18,434.00
EBITDA
-4,858.00
-8,714.00
-16,771.00
-16,888.00
-15,869.00
Reconciled Cost of Revenue
22,238.00
18,639.00
13,145.00
15,102.00
10,998.00
Reconciled Depreciation
3,749.00
3,515.00
3,406.00
2,764.00
2,565.00
Net Income from Continuing Operation Net Minority Interest
-16,628.00
-14,383.00
-19,914.00
-19,601.00
-19,774.00
Total Unusual Items Excluding Goodwill
-8,765.00
-2,852.00
--
--
--
Total Unusual Items
-8,765.00
-2,852.00
--
--
--
Normalized EBITDA
3,907.00
-5,862.00
-16,771.00
-16,888.00
-15,869.00
12/31/2020 - 10/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SSKN STRATA Skin Sciences, Inc.
3.0300
+0.33%
 
SRTS Sensus Healthcare, Inc.
8.62
-2.82%
 
SGHT Sight Sciences, Inc.
3.9000
-0.26%
 
AXGN Axogen, Inc.
14.86
+0.13%
 
UTRS Minerva Surgical, Inc.
0.0001
0.00%
 
SIBN SI-BONE, Inc.
13.83
-2.61%
 
NPCE NeuroPace, Inc.
11.08
-3.74%
 
RXST RxSight, Inc.
37.58
-4.06%
 
ASAPF Aurora Spine Corporation
0.3000
+3.45%
 
DCTH Delcath Systems, Inc.
12.27
+5.23%